All You Need to Know About Service Corp. (SCI) Rating Upgrade to Buy — Positive

SCI   Zacks Investment Research — September 19, 2025

Service Corp. (SCI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

image for news All You Need to Know About Service Corp. (SCI) Rating Upgrade to Buy

Ralph Lauren (RL) Is Up 1.00% in One Week: What You Should Know — Positive

RL   Zacks Investment Research — September 19, 2025

Does Ralph Lauren (RL) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news Ralph Lauren (RL) Is Up 1.00% in One Week: What You Should Know

Universal Health Services (UHS) Upgraded to Buy: What Does It Mean for the Stock? — Positive

UHS   Zacks Investment Research — September 19, 2025

Universal Health Services (UHS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

image for news Universal Health Services (UHS) Upgraded to Buy: What Does It Mean for the Stock?

Are You Looking for a Top Momentum Pick? Why Flowserve (FLS) is a Great Choice — Positive

FLS   Zacks Investment Research — September 19, 2025

Does Flowserve (FLS) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news Are You Looking for a Top Momentum Pick? Why Flowserve (FLS) is a Great Choice

All You Need to Know About Masimo (MASI) Rating Upgrade to Strong Buy — Positive

MASI   Zacks Investment Research — September 19, 2025

Masimo (MASI) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news All You Need to Know About Masimo (MASI) Rating Upgrade to Strong Buy

Halozyme Therapeutics (HALO) Is Up 2.63% in One Week: What You Should Know — Positive

HALO   Zacks Investment Research — September 19, 2025

Does Halozyme Therapeutics (HALO) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news Halozyme Therapeutics (HALO) Is Up 2.63% in One Week: What You Should Know

What Makes Barrett (BBSI) a New Buy Stock — Positive

BBSI   Zacks Investment Research — September 19, 2025

Barrett (BBSI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

image for news What Makes Barrett (BBSI) a New Buy Stock

Are You Looking for a Top Momentum Pick? Why Leidos (LDOS) is a Great Choice — Positive

LDOS   Zacks Investment Research — September 19, 2025

Does Leidos (LDOS) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news Are You Looking for a Top Momentum Pick? Why Leidos (LDOS) is a Great Choice

Gorman-Rupp (GRC) Upgraded to Buy: Here's Why — Positive

GRC   Zacks Investment Research — September 19, 2025

Gorman-Rupp (GRC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

image for news Gorman-Rupp (GRC) Upgraded to Buy: Here's Why

Crexendo (CXDO) Is Up 2.73% in One Week: What You Should Know — Positive

CXDO   Zacks Investment Research — September 19, 2025

Does Crexendo (CXDO) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news Crexendo (CXDO) Is Up 2.73% in One Week: What You Should Know

All You Need to Know About Grand Canyon Education (LOPE) Rating Upgrade to Strong Buy — Positive

LOPE   Zacks Investment Research — September 19, 2025

Grand Canyon Education (LOPE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

image for news All You Need to Know About Grand Canyon Education (LOPE) Rating Upgrade to Strong Buy

Verastem (VSTM) Upgraded to Buy: Here's What You Should Know — Positive

VSTM   Zacks Investment Research — September 19, 2025

Verastem (VSTM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news Verastem (VSTM) Upgraded to Buy: Here's What You Should Know

Are You Looking for a Top Momentum Pick? Why AirSculpt Technologies, Inc. (AIRS) is a Great Choice — Positive

AIRS   Zacks Investment Research — September 19, 2025

Does AirSculpt Technologies, Inc. (AIRS) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news Are You Looking for a Top Momentum Pick? Why AirSculpt Technologies, Inc. (AIRS) is a Great Choice

All You Need to Know About Fiverr (FVRR) Rating Upgrade to Buy — Positive

FVRR   Zacks Investment Research — September 19, 2025

Fiverr (FVRR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news All You Need to Know About Fiverr (FVRR) Rating Upgrade to Buy

What Makes Daktronics (DAKT) a Strong Momentum Stock: Buy Now? — Positive

DAKT   Zacks Investment Research — September 19, 2025

Does Daktronics (DAKT) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news What Makes Daktronics (DAKT) a Strong Momentum Stock: Buy Now?

Gold Fields (GFI) Upgraded to Strong Buy: Here's What You Should Know — Positive

GFI   Zacks Investment Research — September 19, 2025

Gold Fields (GFI) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news Gold Fields (GFI) Upgraded to Strong Buy: Here's What You Should Know

Can MRK's New Drugs Drive Long-Term Growth Amid Looming Keytruda LOE? — Positive

MRK   Zacks Investment Research — September 19, 2025

Merck eyes new launches like Capvaxive and Winrevair, among others, to drive long-term growth as Keytruda nears loss of exclusivity.

image for news Can MRK's New Drugs Drive Long-Term Growth Amid Looming Keytruda LOE?

VRT's Robust Portfolio Fuels Revenue Growth: A Sign of More Upside? — Positive

VRT   Zacks Investment Research — September 19, 2025

Vertiv's diversified portfolio, strong order growth, and new data center solutions are fueling double-digit revenue gains.

image for news VRT's Robust Portfolio Fuels Revenue Growth: A Sign of More Upside?

Here's Why You Should Retain RenaissanceRe Stock for Now — Positive

RNR   Zacks Investment Research — September 19, 2025

RNR's premium growth, acquisitions, strong cash returns and undervaluation support its stock despite rising costs and debt pressure.

image for news Here's Why You Should Retain RenaissanceRe Stock for Now

HTGC's Baa2 Credit Rating Upgraded by Moody's, Outlook Stable — Positive

HTGC   Zacks Investment Research — September 19, 2025

Moody's lifts Hercules Capital's credit rating to Baa2 with a stable outlook, citing strong performance, low leverage and solid asset quality.

image for news HTGC's Baa2 Credit Rating Upgraded by Moody's, Outlook Stable